Evaluating the Impact AI Avatar-led Mental Health Interventions for Keeping Employees in Work
1 other identifier
interventional
50
1 country
1
Brief Summary
This study will examine whether an artificial intelligence (AI) avatar-led mental health programme can help employees experiencing symptoms of depression. The programme delivers structured, self-guided psychological support over several short sessions that participants complete online over a period of several weeks. Approximately 50-80 adults will take part. Participants will be randomly assigned either to start the AI programme immediately or to continue with their usual support and access the programme later. All participants will complete questionnaires before and after the study period to assess changes in mood, anxiety, and work functioning. Some participants will also be invited to take part in brief interviews to share their experiences of using the programme. The aim of the study is to evaluate whether this AI-based intervention can improve mental health and workplace functioning, and to assess how acceptable and safe it is for use in a working population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Oct 2025
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 7, 2025
CompletedFirst Submitted
Initial submission to the registry
February 16, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
February 27, 2026
February 1, 2026
9 months
February 16, 2026
February 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Depression (PHQ-9)
First measure at baseline, second measure 1 week post-intervention in treatment condition or 6 weeks after baseline in the control condition.
Secondary Outcomes (6)
Anxiety (GAD-7)
First measure at baseline, second measure 1 week post-intervention in treatment condition or 6 weeks after baseline in the control condition.
Absenteeism
First measure at baseline, second measure 1 week post-intervention in treatment condition or 6 weeks after baseline in the control condition.
Productivity
First measure at baseline, second measure 1 week post-intervention in treatment condition or 6 weeks after baseline in the control condition.
Concentration at Work
First measure at baseline, second measure 1 week post-intervention in treatment condition or 6 weeks after baseline in the control condition.
Relationships with Colleagues
First measure at baseline, second measure 1 week post-intervention in treatment condition or 6 weeks after baseline in the control condition.
- +1 more secondary outcomes
Study Arms (2)
AI-avatar led CBT course
EXPERIMENTALTreatment as usual
NO INTERVENTIONInterventions
The InsideOut AI programme for low mood is based on principles of Cognitive Behavioral Therapy (CBT), adapted into a self-paced, avatar-led format. Participants in the intervention group will complete six sessions over a four to six-week period, each lasting 10-15 minutes. The sessions will cover the following key components: 1. Session 1-2: Psychoeducation on depression and the role of CBT. 2. Session 3-4: Cognitive restructuring techniques to challenge negative thought patterns. 3. Session 5-6: Coping behavioural strategies for managing low mood and preventing relapse. The programme is designed to be fully automated, with personalised feedback provided by the AI avatar based on participants' responses and progress. Throughout the programme, participants will also complete self-check-ins to track their mood and identify progress. Engagement and adherence to the programme will be monitored through the platform's data analytics, allowing us to track session completion rates and user int
Eligibility Criteria
You may qualify if:
- Participants will be eligible if they currently experience symptoms of depression (score above 5 on the PHQ-9)
- Participants should be aged 18 or above.
- Participants need to be resident in the UK.
You may not qualify if:
- Participants with frequent thoughts of suicide/self-harm will be excluded (scoring above 2 on Question 9 of the PHQ-9 "Thoughts that I would be dead or hurting myself in some way")
- Participants who are currently undergoing other forms of therapy will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Roehampton
London, SW15 4JD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
February 16, 2026
First Posted
February 27, 2026
Study Start
October 7, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02